Skip to main content
Caplight Logo









Fluigent

Fluigent

Private
Le Kremlin-BicêtreHealthcare & Life Scienceshttps://www.fluigent.com/

Last Round

VC Round

Aug 30, 2018

Total Funding Raised

$8.38M

Company Overview

Fluigent is a biotechnology company that develops, manufactures, and supports advanced fluid control systems for microfluidics applications.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Medical Devices, Drug Discovery, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Hardware + Subscription

AI Layer

Non-AI

Keywords

microfluidic flow controllerspressure-based flow controlmicrofluidicsorgan-on-a-chippulseless flowlab-on-a-chipfluid handling systemsscientific instrumentslab automationbiotech equipmentdrug discovery toolsnanofluidicsOEM modulescell-based assaysmicrofluidic pump

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fluigent Comparables

Compare Fluigent with similar companies based on industry and business-model similarity.

Fluigent comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Elveflow
91%
Randox
81%
PreciGenome
80%

Fluigent Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 30, 2018
GrantMay 2, 2018

Key People

Founding team and executive leadership

France Hamber

CEO

Executive Team

Sabine Mercier

General Secretary - CFO COO - Member Of The Board

Executive Team

Fluigent Investors

Notable investors and investment history

Fluigent investors
InvestorRounds
The Innovation FundVC Round
European CommissionGrant
InVenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 19, 2026

    Grew 18% QoQ, from 38 to 45 employees.

  • Jul 6, 2025

    Monthly visitors grew 47% MoM, reaching 21K.

Fluigent Filings

Explore SEC and related filing metadata, where available.

Fluigent filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Fluigent's valuation, stock price, and market status.

Is Fluigent a public or private company?

Fluigent is a private company.

What is the current stock price of Fluigent?

Fluigent is a private company with no public stock price. No recent secondary market data is available.

How much is Fluigent worth (valuation)?

Valuation information for Fluigent is not publicly available.

Can I buy Fluigent stock?

Fluigent shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Fluigent's last funding round?

Fluigent's most recent funding round was VC Round on August 30, 2018.

Who are the main investors in Fluigent?

Key investors in Fluigent include European Commission, InVentures.

Will Fluigent IPO soon?

No public IPO plans have been announced for Fluigent.

How can I track Fluigent secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Fluigent's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLe Kremlin-Bicêtre
Employee Range39
Year Founded2005
Last FundingAug 30, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?